Zacks: Brokerages Expect Akari Therapeutics PLC (AKTX) to Post -$1.00 EPS

Retrieved on: 2018-03-06 00:07:30

Tags for this article:

Economy

Financial analyst

Securities research

Occupations

Celsus Therapeutics Plc

Akari Therapeutics Plc

Click the tags to see associated articles and topics

Zacks: Brokerages Expect Akari Therapeutics PLC (AKTX) to Post -$1.00 EPS. View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> LLC increased its holdings in Akari Therapeutics by 125.0% during the fourth quarter. <b>Millennium Management</b> LLC now owns 260,020 shares of the biopharmaceutical company's stock valued at $1,126,000 after buying an additional 144,477 shares during the last quarter.</div>

Article found on:

View Original Article